135 related articles for article (PubMed ID: 8732159)
1. Targeting of retroviral vectors through protease-substrate interactions.
Nilson BH; Morling FJ; Cosset FL; Russell SJ
Gene Ther; 1996 Apr; 3(4):280-6. PubMed ID: 8732159
[TBL] [Abstract][Full Text] [Related]
2. Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectors.
Peng KW; Pham L; Ye H; Zufferey R; Trono D; Cosset FL; Russell SJ
Gene Ther; 2001 Oct; 8(19):1456-63. PubMed ID: 11593358
[TBL] [Abstract][Full Text] [Related]
3. Lack of specificity of cell-surface protease targeting of a cytotoxic hyperfusogenic gibbon ape leukaemia virus envelope glycoprotein.
Kirkham LA; Bateman AR; Melcher AA; Vile RG; Fielding AK
J Gene Med; 2002; 4(6):592-600. PubMed ID: 12439851
[TBL] [Abstract][Full Text] [Related]
4. Selective transduction of protease-rich tumors by matrix-metalloproteinase-targeted retroviral vectors.
Peng KW; Vile R; Cosset FL; Russell S
Gene Ther; 1999 Sep; 6(9):1552-7. PubMed ID: 10490764
[TBL] [Abstract][Full Text] [Related]
5. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles.
Schnierle BS; Moritz D; Jeschke M; Groner B
Gene Ther; 1996 Apr; 3(4):334-42. PubMed ID: 8732165
[TBL] [Abstract][Full Text] [Related]
6. Retroviral vector targeting through insertion of epidermal growth factor into receptor binding deficient influenza A hemagglutinin results in fusion defective particles.
Haynes C; Schnierle BS
J Virol Methods; 2004 Sep; 120(2):189-99. PubMed ID: 15288962
[TBL] [Abstract][Full Text] [Related]
7. Retroviral cell targeting vectors.
Buchholz CJ; Stitz J; Cichutek K
Curr Opin Mol Ther; 1999 Oct; 1(5):613-21. PubMed ID: 11249668
[TBL] [Abstract][Full Text] [Related]
8. Inverse targeting of retroviral vectors: selective gene transfer in a mixed population of hematopoietic and nonhematopoietic cells.
Fielding AK; Maurice M; Morling FJ; Cosset FL; Russell SJ
Blood; 1998 Mar; 91(5):1802-9. PubMed ID: 9473249
[TBL] [Abstract][Full Text] [Related]
9. Masking of retroviral envelope functions by oligomerizing polypeptide adaptors.
Morling FJ; Peng KW; Cosset FL; Russell SJ
Virology; 1997 Jul; 234(1):51-61. PubMed ID: 9234946
[TBL] [Abstract][Full Text] [Related]
10. Cell targeting with retroviral vector particles containing antibody-envelope fusion proteins.
Chu TH; Martinez I; Sheay WC; Dornburg R
Gene Ther; 1994 Sep; 1(5):292-9. PubMed ID: 7584094
[TBL] [Abstract][Full Text] [Related]
11. Modification of retroviral tropism by display of IGF-I.
Chadwick MP; Morling FJ; Cosset FL; Russell SJ
J Mol Biol; 1999 Jan; 285(2):485-94. PubMed ID: 9878423
[TBL] [Abstract][Full Text] [Related]
12. Modifying the host range properties of retroviral vectors.
Russell SJ; Cosset FL
J Gene Med; 1999; 1(5):300-11. PubMed ID: 10738547
[TBL] [Abstract][Full Text] [Related]
13. In vivo selection of protease cleavage sites from retrovirus display libraries.
Buchholz CJ; Peng KW; Morling FJ; Zhang J; Cosset FL; Russell SJ
Nat Biotechnol; 1998 Oct; 16(10):951-4. PubMed ID: 9788352
[TBL] [Abstract][Full Text] [Related]
14. A hyperfusogenic gibbon ape leukemia envelope glycoprotein: targeting of a cytotoxic gene by ligand display.
Fielding AK; Chapel-Fernandes S; Chadwick MP; Bullough FJ; Cosset FL; Russell SJ
Hum Gene Ther; 2000 Apr; 11(6):817-26. PubMed ID: 10779159
[TBL] [Abstract][Full Text] [Related]
15. An essential role for the His-8 residue of the SDF-1alpha-chimeric, tropism-redirected Env protein of the Moloney murine leukemia virus in regulating postbinding fusion events.
Katane M; Fujita R; Takao E; Kubo Y; Aoki Y; Amanuma H
J Gene Med; 2004 Mar; 6(3):260-7. PubMed ID: 15026987
[TBL] [Abstract][Full Text] [Related]
16. A gene delivery system activatable by disease-associated matrix metalloproteinases.
Peng KW; Morling FJ; Cosset FL; Murphy G; Russell SJ
Hum Gene Ther; 1997 Apr; 8(6):729-38. PubMed ID: 9113512
[TBL] [Abstract][Full Text] [Related]
17. Intramembrane cleavage of ephrinB3 by the human rhomboid family protease, RHBDL2.
Pascall JC; Brown KD
Biochem Biophys Res Commun; 2004 Apr; 317(1):244-52. PubMed ID: 15047175
[TBL] [Abstract][Full Text] [Related]
18. Targeted retroviral vectors displaying a cleavage site-engineered hemagglutinin (HA) through HA-protease interactions.
Szécsi J; Drury R; Josserand V; Grange MP; Boson B; Hartl I; Schneider R; Buchholz CJ; Coll JL; Russell SJ; Cosset FL; Verhoeyen E
Mol Ther; 2006 Nov; 14(5):735-44. PubMed ID: 16784893
[TBL] [Abstract][Full Text] [Related]
19. Receptor-specific targeting mediated by the coexpression of a targeted murine leukemia virus envelope protein and a binding-defective influenza hemagglutinin protein.
Lin AH; Kasahara N; Wu W; Stripecke R; Empig CL; Anderson WF; Cannon PM
Hum Gene Ther; 2001 Mar; 12(4):323-32. PubMed ID: 11242525
[TBL] [Abstract][Full Text] [Related]
20. Replicating retroviral vectors mediating continuous production and secretion of therapeutic gene products from cancer cells.
Finger C; Sun Y; Sanz L; Alvarez-Vallina L; Buchholz CJ; Cichutek K
Cancer Gene Ther; 2005 May; 12(5):464-74. PubMed ID: 15692609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
